Sexual Health Information for Health Professionals
Toronto Public Health promotes and celebrates healthy sexuality. Our Sexual Health programs and services follow the Ontario Public Health Standards.
June 5, 2017
TPH is recommending the use of Expedited Partner Therapy (EPT) – also known as Patient-Delivered Partner Therapy – for the treatment of contacts of chlamydia who may not otherwise receive treatment.
Hepatitis A Increase in MSM in Toronto
September 29, 2017
In 2017-to-date, compared to previous years, TPH has noted an increase in reported hepatitis A cases among men who have sex with men (MSM) and who have not reported international travel. TPH’s Communiqué newsletter for additional information.
Infectious Syphilis and Lymphogranuloma Venereum Cases Increase Significantly
Updated August 3, 2017
Toronto is experiencing a significant increase in the number of reported cases of infectious syphilis and lymphogranuloma venereum in men who have sex with men (MSM). Health care providers are reminded about the importance of regularly testing MSM who may be engaging in unprotected anal or oral sex for sexually transmitted infections.
Gonorrhea Rates in Toronto Continue to Rise
Toronto Public Health has noted an increase in the incidence of gonorrhea infections in 2014. From January to September 2014, a total of 2,040 cases were reported in Toronto, a 26 per cent increase from the same time period in 2013 (n=1,614). The number of gonorrhea reports in 2013 (n=2,214) was the highest annual number over the 11-year surveillance period, driven primarily by a 22 per cent increase in reports among males.
An increase in the number of gonorrhea infections has also been seen across the province in other parts of Ontario. Rising gonorrhea infection rates, in addition to increasing antimicrobial resistance at the local, national and global level are of great concern at this time; treatment failures have been reported in several jurisdictions across Ontario, associated with the use of oral cefixime. Left untreated, gonorrhea infection can lead to a number of short and long-term complications, including pelvic inflammatory disease, disseminated gonococcal infection and infertility. Moreover, gonorrhea also increases the risk of HIV acquisition and transmission.
Due to the increasingly important nature of this infection, site-specific testing of all sexually active individuals is critical in diagnosing gonorrhea infection, particularly as up to 50 per cent of women and 10 per cent of men with urogenital infections are asymptomatic, while rectal and pharyngeal infections are often asymptomatic.
Prompt diagnosis of gonorrhea infection facilitates treatment, prevents complications and reduces further transmission. Health care providers in Ontario are encouraged to follow Public Health Ontario’s Guidelines for Testing and Treatment of Gonorrhea in Ontario (2013). This document is informed by provincial resistance data and presents current recommendations for gonorrhea testing and treatment.
- Toronto Public Health. Reportable Communicable Diseases Monthly Report September 2014. Retrieved November 27, 2014, from TPH’s Archived Reports
- Integrated Public Health Information System (iPHIS). Ontario Ministry of Health and Long-Term Care, iPHIS. Extracted [11/09/2014].
- Ontario Agency for Health Protection and Promotion (Public Health Ontario). Guidelines for testing and treatment of gonorrhea in Ontario. Toronto, ON: Queen’s Printer for Ontario; 2013.
- Public Health Agency of Canada. Canadian guidelines on sexually transmitted infections. Ottawa, ON: Her Majesty the Queen in Right of Canada; 2008.
- Bignell C; IUSTI/WHO. 2009 European (IUSTI/WHO) guideline on the diagnosis and treatment of gonorrhoea
Toronto Public Health provides free STI medications to all City of Toronto health care providers and medical clinics, for the treatment of chlamydia, gonorrhea, and syphilis. All patients diagnosed with a reportable STI and their partners, regardless of OHIP status, are eligible for the following free STI medications:
- Penicillin G Benzathine (Bicillin)
To order the above medications, send the completed STI Medication Order form as an email attachment to firstname.lastname@example.org by clicking the Submit STI Drug Order button at the bottom of the form (preferable option), or fax to 416-338-0002. Please ensure all the fields in the ordering health care information section is completed, as only forms with complete information will be processed.
Note: Fillable PDF forms are not supported by Firefox. Please use a different browser or save the form to your computer before completing. If sending forms via email, please save to your computer before sending.
- Bacterial STI Testing: Quick Reference – Public Health Ontario (PHO)
- Canadian Guideline on HIV Pre-exposure Prophylaxis and Non-occupational Post-exposure Prophylaxis
- Canadian Guidelines on STI – Public Health Agency of Canada
- Canadian HIV Pregnancy Planning Guidelines – Journal of Obstetrics and Gynaecology Canada
- Ceftriaxone reconstitution guidelines – Toronto Public Health (TPH)
- Gonorrhea – Public Health Ontario
- Gonorrhea Treatment Quick Reference for Adolescents and Adults – (PHO)
- HIV Prevention: Pre-exposure prophylaxis (PEP) and Pre-exposure prophylaxis (PrEP) – Government of Canada
- STI Treatment Quick Reference Guide – Toronto Public Health
- Syphilis Laboratory Interpretation Guide -TPH
- TPH Full list of Treatment guidelines – TPH